COMPANY

Acrivon Therapeutics

HQ: Watertown, MA source · acrivon.com ↗

Clinical Phase 2

2 open jobs · last seen Oct 23, 2026 · 2 sources

Keywords: precision medicine Specific Advanced Solid Tumors Endometrial Adenocarcinoma ACR-2316 ACR-368

Location: Watertown, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

2Open jobs 2Trials (company is sponsor)

Hiring

Title	Location (from posting)	Employer posted	First seen
Executive Assistant	Watertown, Massachusetts	Not stated	Oct 11, 2026
Vice President or Senior Vice President, Head, Drug Discovery & Biology	Watertown, Massachusetts	Not stated	Oct 11, 2026

See all 2 jobs

Timeline

Oct 8, 2024 Trial start Phase 1/Phase 2: Study of ACR-2316 in Specific Advanced Solid Tumors source ↗
Aug 29, 2022 Trial start 2: A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma source ↗

Upcoming milestones

May 30, 2027 (ESTIMATED) · 2 · A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma · NCT05548296
Aug 12, 2027 (ESTIMATED) · Phase 1/Phase 2 · Study of ACR-2316 in Specific Advanced Solid Tumors · NCT06667141

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT06667141	Study of ACR-2316 in Specific Advanced Solid Tumors	Phase 1/Phase 2	Recruiting	Oct 8, 2024	Aug 12, 2027 (estimated)
NCT05548296	A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma	2	Recruiting	Aug 29, 2022	May 30, 2027 (estimated)

Open jobs 2

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Executive Assistant	Watertown, Massachusetts	Not stated	Oct 11, 2026	Mid
Vice President or Senior Vice President, Head, Drug Discovery & Biology	Watertown, Massachusetts	Not stated	Oct 11, 2026	Executive

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.